Pronota
MyCartis Plans to Launch System, Kit Next Month in Bid to Combine Multiple Levels of Omics Data
Premium
NEW YORK (GenomeWeb) – Recently launched Biocartis-Pronota joint venture MyCartis is taking aim at the multi-omics space, looking to combine genomic, transcriptomic, and proteomic analyses for the development of research and clinical products.
Protein analysis firm Zephyrus Biosciences launched this week with Kelly Gardner as CEO, Josh Molho as chief technology officer, Brock Siegel as chief operating officer, Gary Zweiger as chief business development officer, Jenny Rooke as chief marketing officer, and Chris Hadsell as chief financia
NEW YORK (GenomeWeb) – Diagnostics firm Carmenta Bioscience has begun a multi-center clinical trial for its protein-based preeclampsia diagnostic with the aim of launching the test sometime next year.
Danaher said this week that it has appointed Thomas Joyce as president and CEO and member of the board of directors. He replaces Lawrence Culp, who will transition to a senior advisory role with the company.
Biocartis Raises $84M, Forms JV with Pronota
NEW YORK (GenomeWeb) – Biocartis announced today that it has raised €64.5 million ($84 million) in a round of private financing.
Nov 9, 2012
Jul 13, 2012
Mar 23, 2012
Mar 16, 2012
People In The News: Mar 16, 2012
Jan 30, 2012
Jan 30, 2012
Pronota CEO Resigns as Firm Raises $4.9M
Aug 26, 2011
Movers & Shakers: Aug 26, 2011
Premium
Feb 25, 2011
Feb 22, 2011